Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hospitalized Patients
100%
COVID-19
100%
Patients with Cancer
100%
Systemic Anti-cancer Therapy
100%
Adjusted Risk Ratio
100%
Venous Thromboembolism
70%
Immune Checkpoint Inhibitors
30%
Mechanical Ventilation
20%
Tyrosine Kinase Inhibitor
20%
Chemotherapy
20%
Systemic Therapy
20%
Anticancer Therapy
20%
Intensive Care Unit Admission
20%
Endocrine Therapy
20%
Relative Risk
20%
Vascular Endothelial Growth Factor Inhibitors
20%
Arterial Thromboembolism
20%
Immunomodulatory Drugs (IMiDs)
20%
High Risk
10%
Black Women
10%
Exposure Therapy
10%
Thromboprophylaxis
10%
Multivariable
10%
Retrospective Cohort Study
10%
Thromboembolism
10%
Immunomodulator
10%
Laboratory Confirmation
10%
SARS-CoV-2 Infection
10%
Regression Analysis
10%
Relative Risk of Death
10%
30-day Mortality
10%
White Patients
10%
Close Monitoring
10%
Active Cancer
10%
Log-binomial Regression
10%
Poor Performance Status
10%
Systematic Data
10%
Inpatient Treatment
10%
Registry-based
10%
Therapy Types
10%
Underlying Risk Factors
10%
In(III)
10%
High-risk Sites
10%
Medicine and Dentistry
COVID-19
100%
Thromboembolism
100%
Cancer Treatment
100%
Venous Thromboembolism
87%
Malignant Neoplasm
50%
Immune Checkpoint Inhibitor
37%
Intensive Care Unit
25%
Systemic Therapy
25%
Hormone Therapy
25%
Artificial Respiration
25%
Tyrosine-Kinase Inhibitor
25%
Vasculotropin Inhibitor
25%
Arterial Thromboembolism
25%
Chemotherapy
25%
Infection
12%
Cohort Analysis
12%
All Cause Mortality
12%
Retrospective Cohort Study
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Morbidity
12%
Immunomodulating Agent
12%
Thromboprophylaxis
12%
COVID-19 Diagnosis
12%
Treatment Exposure
12%
Regression Analysis
12%
Nursing and Health Professions
Thromboembolism
100%
COVID-19
100%
Anticancer
100%
Venous Thromboembolism
87%
Malignant Neoplasm
50%
Intensive Care Unit
25%
Hormonal Therapy
25%
Protein Tyrosine Kinase Inhibitor
25%
Artificial Respiration
25%
Cohort Analysis
25%
Systemic Therapy
25%
Chemotherapy
25%
Vasculotropin Inhibitor
25%
Arterial Thromboembolism
25%
Severe Acute Respiratory Syndrome
12%
Infection
12%
Morbidity
12%
All Cause Mortality
12%
Immunomodulating Agent
12%
Exposure Therapy
12%
Regression Analysis
12%
Receiving Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Thromboembolism
100%
Venous Thromboembolism
87%
Immune Checkpoint Inhibitor
37%
Cohort Study
25%
Endocrine Therapy
25%
Chemotherapy Regimens
25%
Protein Tyrosine Kinase Inhibitor
25%
Vasculotropin Inhibitor
25%
Arterial Thromboembolism
25%
Infection
12%
All Cause Mortality
12%
Morbidity
12%
Immunomodulating Agent
12%
SARS Coronavirus
12%
Immunology and Microbiology
COVID-19
100%
Immune Checkpoint Inhibitor
42%
Tyrosine
28%
Kinase
28%
Phosphotransferase
28%
Vasculotropin Inhibitor
28%
Infectious Disease
14%
Immunomodulating Drugs
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Morbidity
14%
All Cause Mortality
14%
Infection
14%